The previous treatment guide for type 2 diabetes was prepared by the Estonian Society of Endocrinology
led in 2016 and discussed type 2 diabetes screening, diagnosis and
pharmacological treatment (1). The guideline was prepared as an expert opinion/consensus and no
followed the agreed methodology, which ...
Clinical question What are the benefits and harms of sodium-glucose cotransporter 2 (SGLT-2) inhibitors and glucagon-like peptide 1 (GLP-1) receptor agonists when added to usual care (lifestyle interventions and/or other diabetes drugs) in adults with type 2 diabetes at different risk for cardiovascular ...
This guideline covers care and management for adults (aged 18 and over) with type 2 diabetes. It focuses on patient education, dietary advice, managing cardiovascular risk, managing blood glucose levels, and identifying and managing long-term complications. In December 2020, we made minor changes to the ...
DESCRIPTION: In April 2017, the U.S. Department of Veterans Affairs (VA) and the U.S. Department of Defense (DoD) approved a joint clinical practice guideline for the management of type 2 diabetes mellitus. METHODS: The VA/DoD Evidence-Based Practice Work Group convened a joint VA/DoD guideline developme...
This guideline covers how to identify adults at high risk of type 2 diabetes. It aims to remind practitioners that age is no barrier to being at high risk of, or developing, the condition. It also aims to help them provide those at high risk with an effective and appropriate intensive lifestyle-change pr...
DESCRIPTION: The American College of Physicians (ACP) developed this guideline to present the evidence and provide clinical recommendations on oral pharmacologic treatment of type 2 diabetes in adults. This guideline serves as an update to the 2012 ACP guideline on the same topic. This guideline is endor...
Entregar recomendaciones para apoyar a los equipos de salud en la toma de decisiones clínicas respecto del tratamiento farmacológico en pacientes adultos con diagnóstico de Diabetes Mellitus tipo
2, basadas en la mejor evidencia científica disponible y el consenso de expertos....
"OBJECTIVE:
To formulate clinical practice guidelines for the use of continuous glucose monitoring and continuous subcutaneous insulin infusion in adults with diabetes.
PARTICIPANTS:
The participants include an Endocrine Society-appointed Task Force of seven experts, a methodologist, and a medical write...
Glucemia,
Terapia Combinada,
Diabetes Mellitus Tipo 1,
Diabetes Mellitus Tipo 2,
Dieta para Diabéticos,
Monitoreo de Drogas,
Endocrinología,
Hiperglucemia,
Hipoglucemia,
Insulina/uso terapéutico,
Sistemas de Infusión de Insulina,
Monitoreo Ambulatorio,
Educación del Paciente como Asunto,
Medicina de Precisión,
Diabetes Mellitus Tipo 1/tratamiento farmacológico,
Diabetes Mellitus Tipo 2/tratamiento farmacológico,
Diabetes Mellitus Tipo 1/terapia,
Diabetes Mellitus Tipo 2/terapia,
Hipoglucemiantes/uso terapéutico,
Hipoglucemiantes/efectos adversos,
Insulina/efectos adversos
Determinar la utilidad, en nuestro medio, de estrategias de tamización como herramienta
para la detección y diagnóstico temprano de la diabetes mellitus tipo 2. Indicar las intervenciones farmacológicas y dentro de un plan de manejo multifactorial, escalonado de menor a mayor complejidad, haciendo é...
Rahelić, D;
Altabas, V;
Bakula, M;
Balić, S;
Balint, I;
Marković, BB;
Bicanić, N;
Bjelinski, I;
Bozikov, V;
Varzić, SC;
Car, N;
Berković, MC;
Orlić, ZC;
Deskin, M;
Sunić, ED;
Tomić, NG;
Goldoni, V;
Gradiser, M;
Mahecić, DH;
Balen, MJ;
Erzen, DJ;
Majanović, SK;
Kokić', S;
Krnic, M;
Kruljac, I;
Liberati-Cizmek, AM;
Martina, L;
Metelko, Z;
Mirosević, G;
Vrbica, SM;
Renar, IP;
Petric, D;
Prasek, M;
Prpić-Kizevać, I;
Radman, M;
Soldo, D;
Sarić, T;
Tesanović, S;
Kurir, TT;
Wensveen, TT;
Botica, M;
Vrkljan, M;
Rotkvic, VZ;
Zorić, C;
Krznarić, Z.
INTRODUCTION:
The Croatian Association for Diabetes and Metabolic Disorders of the Croatian Medical Association has issued in 2011 the first national guidelines for the nutrition, education, self-control, and pharmacotherapy of diabetes type 2. According to the increased number of available medicines and...
